Abstract Body

Background: Early events during primary HIV infection (PHI) are thought to influence disease outcome. Although few studies have characterized HIVspecific CD4 T cells during PHI, a growing body of evidence suggests a beneficial role of functional CD4 T-cell responses in different aspects of protective immunity in HIV infection. It is unclear how viral replication and systemic immune activation may shape these responses. Here, we longitudinally investigated polyclonal and HIV-specific CD4 T-cells in relationship with the immuno-virological status of patients with PHI. Methodology: 27 patients with early PHI were included in a prospective longitudinal study and followed-up for 6 months. T-cell activation, natural Tregs, Th1, Th17 and Th1/Th17 cells were assessed by cytometry on fresh PBMC. Cytokine-producing effector CD4 T cells were quantified by intracellular cytokine staining on isolated peripheral CD3+CD4+ cells stimulated with PMA/ionomycin for 5h or with the HIV-1 gag p24 antigen for 72h in the presence of autologous monocytes. Statistical significance was assessed using the Mann-Whitney or the Wilcoxon matched-paired non-parametric tests. Results: Two groups of patients were segregated based on the level of CD8 T-cell activation at baseline (the groups with lower immune activation (LIA, n=13) and higher immune activation (HIA, n=14) were defined as % HLA-DR+CD38+ CD8 T cells < median and ≥ median, respectively). Following PMA/ ionomycin activation, compared to patients with HIA, patients with LIA exhibited higher frequency of CD4 T cells producing IFNγ (p=0.039) or IL-17 (p=0.018). Also, patients with LIA exhibited higher effector/regulatory T-cell balance (p=0.001 when considering the Th1/Treg ratio; p=0.039 when considering the Th17/Treg ratio). No differences were found in the frequency of HIV-specific CD4 T cells between both groups. However, patients with plasma viral load (pVL) > median had higher IFNγ+ (p=0.031), IL-2+ (p=0.018), IL17+ (p=0.037) and IFNγ+IL17+ (p=0.009) HIV-specific CD4 T cells compared to patients with pVL < median. Of note, the frequency of IFNγ+ (but not of IL-2+) HIV-specific CD4 T cells significantly diminished between baseline and month 6 only in patients receiving ART during the follow-up (p=0.014). Conclusions: Immune activation in PHI is associated with low polyclonal effector CD4 T cell responses but not related to levels of HIV-specific responses suggesting that immune activation is mainly driven by the virus and innate responses rather than by HIV-specific responses. In addition, the frequency of HIV-specific Th1, Th17 and Th1/Th17 cells is positively associated with plasma viral load, suggesting that these cells are driven by viral replication but not able to contribute to its control in the early phase of infection.